BRIEF published on 06/27/2024 at 16:05, 1 year 7 months ago Neuro20 Sparks Hope for Long COVID Recovery Long Covid Clinical Trials Neuro20 FDA-approved Device Patient Improvement
BRIEF published on 06/27/2024 at 16:05, 1 year 7 months ago Neuro20 suscite l’espoir d’une longue guérison suite au COVID Essais Cliniques Longue COVID Neuro20 Appareil Approuvé Par La FDA Amélioration Des Patients
PRESS RELEASE published on 06/27/2024 at 16:00, 1 year 7 months ago Neuro20 Sparks Hope for Long COVID Recovery Neuro20 Technologies Corp. releases White Paper on patient improvements and potential mechanisms for Long COVID, showcasing the efficacy of their FDA-cleared wearable muscle stimulation device Wearable Device Long Covid White Paper Neuro20 Technologies Corp. FDA Cleared
Published on 02/20/2026 at 18:30, 1 hour 39 minutes ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 4 hours 24 minutes ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 5 hours 39 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 6 hours 1 minute ago Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 6 hours 9 minutes ago Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors
Published on 02/20/2026 at 18:36, 1 hour 32 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 1 hour 38 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 2 hours 9 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 2 hours 9 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
